PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 2, 20260 citations

Cardiac Assessment and Takotsubo-stunning among COPD-exacerbations in-Hospital (CATCH study): when the lungs break your heart-protocol for a prospective observational cohort study.

View Full Paper
RZRickard ZeijlonSZSara ZooqAPAngela Poller

Key Result

The prospective CATCH cohort study will evaluate the incidence of Takotsubo stunning and acute heart failure among 150 adults hospitalized for acute exacerbations of chronic obstructive pulmonary disease.

Key Points

  • The study aims to assess the incidence of Takotsubo stunning during acute exacerbations of chronic obstructive pulmonary disease (AECOPD) and evaluate its clinical impact.
  • Prospective observational cohort study with adults (≥18 years) admitted for AECOPD.
  • Participants undergo echocardiographic screening for regional wall motion abnormalities (RWMA) and left ventricular dysfunction.
  • 150 patients are targeted to detect differences in acute heart failure (AHF) incidence.
  • Primary outcomes measure the incidence of reversible RWMA or left ventricular dysfunction as a proxy for Takotsubo stunning.
  • In-hospital clinical signs of AHF (Killip class >1) are evaluated.

Study Design

Type

Cohort (n=150)

Multicenter

No

Structured PICO

What is the incidence and clinical impact of Takotsubo stunning with acute heart failure during acute exacerbation of COPD?

P
Population
150 adults (≥18 years) admitted for acute exacerbation of chronic obstructive pulmonary disease (AECOPD) at a single center in Sweden. Exclusions: chronic left ventricular systolic dysfunction (LVEF <50%), pre-existing chronic regional wall motion abnormalities (RWMA), or prior type 1 myocardial infarction.
I
Intervention
Echocardiographic screening for regional wall motion abnormalities (RWMA) and/or systolic left ventricular dysfunction, with follow-up echocardiography at 24 hours and 30 days for positive cases.
C
Comparator
Screening-negative participants (patients without reversible dysfunction).
O
Outcome
Incidence of reversible RWMA or left ventricular dysfunction (proxy for Takotsubo stunning) and in-hospital clinical signs of acute heart failure (Killip class >1).surrogate

The CATCH study is a prospective observational cohort designed to determine the incidence and clinical impact of Takotsubo stunning during acute exacerbations of COPD.

Abstract

INTRODUCTION: Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) may cause stress-induced transient acute cardiac dysfunction through myocardial stunning, in the form of exacerbation-triggered Takotsubo syndrome (referred to as Takotsubo stunning). Although prior studies suggest an association between AECOPD and transient cardiac dysfunction, existing evidence is limited to retrospective cohorts, case reports and expert consensus. Therefore, the incidence and clinical impact of Takotsubo stunning with acute heart failure (AHF) during AECOPD remain unknown and may be overlooked due to overlapping clinical symptoms. Cardiac Assessment and Takotsubo-stunning among COPD-exacerbations in-Hospital (CATCH study) aims to determine the incidence of Takotsubo stunning during AECOPD and to evaluate its clinical implication. METHODS AND ANALYSIS: CATCH is a prospective observational cohort study enrolling adults (≥18 years) admitted for AECOPD at Sahlgrenska University Hospital (Gothenburg, Sweden). Participants with chronic left ventricular systolic dysfunction (left ventricular ejection fraction 1). A sample size of 150 patients is required for detecting AHF differences (α=0.05, 80% power). ETHICS AND DISSEMINATION: The study received ethical approval from the Swedish Ethical Review Authority. All participants provided written informed consent. Results will be disseminated through peer-reviewed journals and scientific meetings. REGISTRATION DETAILS: The CATCH study is registered at ClinicalTrials.gov (NCT06597331). The reference number for ethical approval is 2024-02071-01 (with addenda 2024-05448-02 and 2025-05861-02).

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Zeijlon et al. (2026) conducted a cohort in Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) (n=150). Echocardiographic screening for Takotsubo stunning vs. Screening-negative participants was evaluated on Incidence of reversible RWMA or left ventricular dysfunction and in-hospital clinical signs of AHF (Killip class >1). The prospective CATCH cohort study will evaluate the incidence of Takotsubo stunning and acute heart failure among 150 adults hospitalized for acute exacerbations of chronic obstructive pulmonary disease.

synapsesocial.com/papers/69f594e171405d493afffcafhttps://doi.org/10.1136/bmjresp-2025-004079
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Heart and lung, a dangerous liaison-Tako-tsubo cardiomyopathy and respiratory diseases: A systematic review2014 · 32 citations
  2. 2Current State of knowledge on Takotsubo Syndrome: A Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology2015 · 1,220 citations
  3. 3Bronchogenic Stress Cardiomyopathy: A Case Series2015 · 24 citations
  4. 4The stunned myocardium: prolonged, postischemic ventricular dysfunction.1982 · 2,811 citations
  5. 5Prognostic Impact of Acute Pulmonary Triggers in Patients with Takotsubo Syndrome: New Insights from the International Takotsubo Registry2021 · 24 citations